πŸ›’ Your Cart

πŸš€ Free shipping on orders over $200  |  99%+ Purity Guaranteed  |  Same-Day Dispatch Before 2PM EST
πŸ“ US-Based Research Peptide Supplier  |  info@truetide.com
✨ Cosmetic Research CAS: 868844-74-0 βœ“ 99%+ Purity

SNAP-8
Acetyl Octapeptide β€” Neuromuscular Junction Research

β˜…β˜…β˜…β˜…β˜…4.8 / 5  Β·  SNAP-25 research analogue

Select Size

$79
50mg vial
βœ“
99%+ purity, independently verified by HPLC & mass spectrometry
❄
Lyophilized vials β€” shipped with cold pack, stable at βˆ’20Β°C long term
πŸ“„
Certificate of Analysis included with every order
🚚
Same-day dispatch on orders before 2PM EST
πŸ”’
Discreet, unmarked packaging β€” research-grade handling
⚠️ For Research Use Only. SNAP-8 is not approved for human consumption or therapeutic use. This product is sold exclusively as a research chemical for in vitro and laboratory research only.

What is SNAP-8?

SNAP-8 (Acetyl Glutamyl Heptapeptide-3, also Acetyl Octapeptide-3) is a synthetic octapeptide analogue of the N-terminal fragment of SNAP-25 β€” a key SNARE protein involved in synaptic vesicle fusion and acetylcholine release at the neuromuscular junction. By competitively inhibiting SNARE complex formation, SNAP-8 provides a research tool for studying acetylcholine-mediated muscle contraction and neuromuscular signalling modulation.

CAS 868844-74-0 | MW 966.1 Da | Acetyl-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NHβ‚‚

SNARE Complex Inhibition

Competitive inhibitor of SNAP-25 incorporation into SNARE complex, reducing synaptic vesicle docking efficiency at the NMJ.

ACh Release Reduction

SNARE inhibition reduces acetylcholine exocytosis, attenuating NMJ signal transmission β€” measurable via electrophysiological endpoints.

Muscle Contraction Research

Reduced ACh signalling translates to attenuated muscle contraction amplitude β€” studied in facial expression muscle biology.

Botulinum Comparison

SNAP-8 is studied as a mechanistic control compound against BoNT-A in SNARE pathway research β€” same target, different selectivity.

SNARE Complex Modulation

Blanes-Mira et al. established SNAP-8 as a functional analogue of the SNAP-25 N-terminal fragment that competes with endogenous SNAP-25 for SNARE complex assembly, reducing neurotransmitter release in cell-free and cell-based assays.

Int J Cosmet Sci. 2002;24(5):303–310

Electromyography Research

In vitro NMJ models show SNAP-8 reduces ACh-evoked post-synaptic potentials in a dose-dependent manner, confirming SNARE inhibition as mechanism.

J Neurosci Methods. 2008;174(1):82–88

Expression Wrinkle Biology

SNAP-8 reduces muscle contraction-induced wrinkle formation in in vivo research models, studied as a mechanistic tool for expression-line biology.

Int J Cosmet Sci. 2009;31(3):193–201

Research Dosing Protocols

In vitro SNARE assay: 10–500 Β΅M SNAP-8 peptide. NMJ culture models: 50–200 Β΅M. In vivo skin research: 50–500 Β΅g/mL topical application or 10–100 Β΅g intradermal injection per research site. Endpoints: SNARE complex pull-down assay, ACh quantification (Amplex Red), electromyography, and muscle contraction amplitude.

Research Context: Use alongside acetylcholine esterase inhibitors and BoNT-A as controls to map SNARE-mediated vs cholinergic-mediated NMJ research endpoints.
Full NameSNAP-8 (Acetyl Octapeptide-3)
CAS Number868844-74-0
Molecular FormulaC₃₇Hβ‚†β‚ˆN₁₄O₁₅S
Molecular Weight966.1 Da
TargetSNAP-25 / SNARE complex
Purityβ‰₯99% by HPLC
AppearanceWhite lyophilized powder
Storageβˆ’20Β°C, desiccated